期刊文献+

小泛素样修饰蛋白1和P53的表达与子宫平滑肌肉瘤发生的相关性研究 被引量:2

Expression and clinical significance of small ubiquitin-like modifier-1 and P53 protein in uterine leiomyosarcoma
原文传递
导出
摘要 目的了解小泛素样修饰蛋白(SUMO)-1、P53蛋白在子宫平滑肌肉瘤中的表达及其临床意义。方法收集2006年3月—2012年3月期间接受手术治疗的20例子宫平滑肌肉瘤,29例良性子宫平滑肌瘤,采用免疫组织化学Envision法检测各组织中SUMO-1和P53蛋白的表达,对收集的20例子宫平滑肌肉瘤患者进行电话随访预后情况。结果 SUMO-1、P53在子宫平滑肌肉瘤组中阳性表达率分别为85%、30%;在子宫平滑肌瘤组中阳性表达率分别为52%和0%;子宫平滑肌肉瘤组中的SUMO-1阳性表达率明显高于子宫平滑肌瘤组(P<0.01);子宫平滑肌肉瘤组中的P53阳性表达率明显高于子宫平滑肌瘤组(P<0.01);子宫平滑肌肉瘤中SUMO-1与P53蛋白表达无明显相关性;SUMO-1、P53蛋白的表达分别与子宫平滑肌肉瘤预后均无相关性(P>0.05)。结论 P53可能与子宫平滑肌肉瘤的发生机制相关,并对子宫平滑肌肉瘤与子宫平滑肌瘤有一定的鉴别诊断价值;SUMO-1可能与子宫平滑肌肉瘤的发生密切相关。 Objective To learn the expression and significance of small ubiquitin-like modifier(SUMO)-1 and P53 protein in uterine leiomyosarcoma. Methods From March 2006 to March 2012, 20 cases of uterine leiomyosarcoma and 29 cases of uterine leiomyoma were collected. Immunohistochemical Envision method was used to detecte the expression level of SUMO-1 and P53 in 49 cases with uterine sarcoma, and prognosis was followed up by telephone in 20 cases of uterine leiomyosarcoma. Results The positive expression rates of SUMO-1 and P53 in uterine leiomyosarcoma were 85% and 30%, respectively; the positive expression rates of SUMO-1 and P53 in uterine leiomyoma were 52% and 0%, respectively; the positive expression rate of SUMO-1 in uterine leiomyosarcoma was significantly higher than that in uterine leiomyoma(P0.01); the positive expression rate of P53 in uterine leiomyosarcoma was significantly higher than that in uterine leiomyoma(P0.01); the expressions of SUMO-1 and P53 protein in uterine leiomyosarcoma were not associated with prognosis(P0.05). Conclusion P53 may be implicated in the pathogenesis of uterine leiomyosarcoma and is useful in differentiating uterine leiomyosarcoma from uterine leiomyoma. SUMO-1 could be closely related to the occurrence of uterine leiomyosarcoma.
作者 诸葛丽芳 周坚红 曲凡 李娟清 兰义兵 周彩云 Zhuge Li fang;Zhou Jianhong;Qu Fan;Li Juanqing;Lan Yibing;Zhou Caiyun;(Department of Gynaecology,Women’s Hospital School of Medicine Zhejiang University;Department of Traditional Chinese Medicine,Women’s Hospital School of Medicine Zhejiang University;Department of Pathology Women’s Hospital School of Medicine Zhejiang University)
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2018年第2期122-126,共5页 Chinese Journal of Reproduction and Contraception
基金 浙江省自然基金(LY18H040003)~~
关键词 小泛素样修饰蛋白(SUMO)-1 P53 子宫平滑肌瘤 子宫平滑肌肉瘤 免疫组织化学 Small ubiquitin-like modifier (SUMO)-I P53 Uuterine leiomyoma Uterineleiomyosarcoma Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献28

  • 1FEN G YJ, SHEN K. Obstetrics and Gynecology[M]. 2nd ed. Beijing: People's Medical Publishing House, 2010: 334-335.
  • 2Chinese SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012[J]. CA Cancer Clin, 2012, 62(1): 10-29.
  • 3CARTER S, BISCHOF O, DEJEAN A, et al. C-terminal modifi- cations regulate MDM2 dissociation and nuclear export of p53[J]. Nat Cell Biol, 2007, 9(4): 428-435.
  • 4PFANDER B, MOLDOVAN GL, SACHER M, et at. SUMO-modi- fled PCNA recruits Srs2 to prevent recombination during S phase [J]. Nature, 2005, 436(7049): 428-433.
  • 5MELCHIOR F. SUMO-nonelassical ubiqnitin [J]. Annu Rev Cell Dev Biol, 2000(16): 591-626.
  • 6LIU HW, ZHANG J, HEINE GEORGE F, et at. Chromatin modification by SUMO-1 stimulates the promoters of translation machinery ganes[J]. Nucleic Acids Res, 2012, 40(20): 10172- 10186.
  • 7MULLER S, MATUNIS MJ, DEJEAN A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus[J]. EMBO J, 1998, 17(01): 61-70.
  • 8WEGER STEEAN, HAMMER EVA, HEILBRONN REGINE. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vi- vo[J]. FEBS Lett, 2005, 579(22): 5007-5012.
  • 9HINDLEY C, PHILPOTY A. The cell cycle and pluripotency[J]. Biochem J, 2013, 451(2): 135-143.
  • 10WANG XW, ZHAO XC, GAO X, et al. A new role of p53 in regulating lipid metabolism[J]. J Mol Cell Biol, 2013, 5(2): 147-150.

共引文献3

同被引文献8

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部